Core Viewpoint - Zhendemedical (振德医疗) has experienced a stock price increase of 6.57% this week, closing at 23.68 yuan, with a total market capitalization of 6.31 billion yuan as of August 15, 2025 [1] Company Announcements - The company held its fourth board meeting, electing Mr. Lu Jianguo as chairman and Ms. Shen Zhenfang as vice-chairman, with a term of three years. A new executive team was also appointed, including positions such as general manager and financial officer [1] - The first extraordinary general meeting of 2025 was held on August 11, 2025, in Shaoxing, Zhejiang, where multiple proposals were approved, including the fourth board's remuneration plan and the cancellation of the supervisory board [2] Share Capital Changes - Zhendemedical will cancel 615,667 unvested shares from the first employee stock ownership plan, reducing the total share capital from 266,451,202 shares to 265,835,535 shares [3][4]

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Zhendermedical, which closed at 23.68 yuan with a PE ratio of 17.38, marking a new low in 165 days, and a total market capitalization of 6.31 billion yuan [1][2] - The average PE ratio for the medical device industry is 56.58, with a median of 39.97, positioning Zhendermedical at 37th place within the industry [1][2] - As of March 31, 2025, Zhendermedical has 24,690 shareholders, an increase of 1,808 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Group 2 - Zhendermedical specializes in the research, production, and sales of medical and health products, with key offerings in basic care, surgical infection control, pressure treatment, stoma care, and modern wound care [1] - The latest quarterly report for Q1 2025 shows Zhendermedical achieved a revenue of 999.2 million yuan, a year-on-year increase of 2.87%, while net profit was 51.24 million yuan, reflecting a year-on-year decrease of 30.19%, with a gross margin of 34.28% [1]

截至2025年一季报，共有3家机构持仓振德医疗，其中基金3家，合计持股数145.13万股，持股市值0.31 亿元。 8月14日，振德医疗今日收盘23.22元，下跌1.32%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到17.04倍，总市值61.87亿元。 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均55.76倍，行业中值39.14倍，振德医疗排 名第36位。 序号股票简称PE(TTM)PE(静)市净率总市值(元)5振德医疗17.0416.061.0861.87亿行业平均 55.7651.784.91117.92亿行业中值39.1439.592.8556.79亿1九安医疗11.1811.310.88188.72亿2英科医疗 14.7815.931.32233.49亿3山东药玻16.1716.211.86152.90亿4新华医疗16.3115.111.33104.53亿6奥美医疗 17.0716.731.7561.68亿7九强生物17.6516.412.1687.42亿8康德莱18.2218.241.5139.27亿9奥泰生物 18.4419.441.4958.81亿10维力医疗18.4 ...

最新一期业绩显示，2025年一季报，公司实现营业收入9.92亿元，同比2.87%；净利润5124.19万元，同 比-30.19%，销售毛利率34.28%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)5振德医疗17.3716.371.1063.04亿行业平均 57.5153.344.97120.28亿行业中值41.2539.962.9558.75亿1九安医疗11.2611.380.89189.95亿2英科医疗 15.0516.231.34237.81亿3山东药玻16.1716.221.86152.96亿4新华医疗16.9415.701.38108.60亿6奥美医疗 17.5417.191.8063.39亿7九强生物17.9216.672.2088.77亿8康德莱18.7518.761.5540.40亿9维力医疗 18.7920.082.3644.05亿10奥泰生物19.3120.361.5661.58亿11鱼跃医疗20.2319.842.73358.29亿12安图生物 21.1920.232.72241.60亿 8月12日，振德医疗今日收盘23.66元，上涨3.59%，滚动市盈率PE（当前股价与前四 ...

Company Overview - Zhendermedical's latest stock price is 23.66 yuan, an increase of 0.82 yuan from the previous trading day [1] - The stock reached a high of 24.46 yuan and a low of 22.66 yuan during the trading session, with a total transaction amount of 2.08 billion yuan [1] - The company held its fourth first board meeting on August 11, where it approved the election of the chairman and other proposals [1] Business Operations - Zhendermedical's main business is the production and sales of medical dressings, which accounts for 99.61% of the company's revenue [1] - The company operates within the medical device industry and is registered in Zhejiang Province [1] Market Activity - On the morning of August 12, Zhendermedical experienced a rapid pullback, with a decline of over 2% within five minutes [1] - By the end of the trading day, the net inflow of main funds was 5.93 million yuan, while the cumulative net outflow over the past five trading days was 8.31 million yuan [1]

Group 1 - The company has decided to change the purpose of repurchased shares from "for employee stock ownership plan" to "cancellation and reduction of registered capital" [1] - After the cancellation of repurchased shares, the total share capital will decrease from 266,451,202 shares to 265,835,535 shares, and the registered capital will decrease from 266,451,202 yuan to 265,835,535 yuan [1] - The company is notifying creditors that they have the right to request debt repayment or guarantees within 30 days of receiving the notice, or within 45 days from the date of this announcement if they have not received a notice [2] Group 2 - Creditors must provide valid debt documents and related evidence to claim their debts, and the company will continue to fulfill its obligations according to the original debt documents [2] - The company outlines the necessary materials for creditors to declare their debts, including contracts and identification documents [2] - Creditors can submit their claims through various methods, including in-person, by mail, or via email, with specific guidelines for each method [2]

证券代码：603301 证券简称：振德医疗 公告编号：2025-030 （1）董事会战略委员会：董事会战略委员会由四人组成，其中 独立董事两人。公司董事长鲁建国先生为董事会战略委员会主任委员， 董事徐大生先生、独立董事倪崖先生、独立董事李生校先生为董事会 战略委员会委员。 （2）董事会审计委员会：董事会审计委员会由三人组成，其中， 独立董事两人。公司独立董事朱茶芬女士为董事会审计委员会主任委 员，董事沈振芳女士、独立董事李生校先生为审计委员会委员。 振德医疗用品股份有限公司 第四届董事会第一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 振德医疗用品股份有限公司（以下简称"公司"）第四届董事会 第一次会议于 2025 年 8 月 11 日在公司会议室以现场方式召开，第四 届董事会全体董事一致同意豁免本次会议提前通知时限，与会董事均 已知悉与所议事项相关的必要信息。本次会议由公司董事鲁建国先生 主持，会议应出席董事 9 名，实际出席董事 9 名，公司高级管理人员 列席了本次会议，符合《公司法》和《公司章程》的有关 ...

| 证券代码：603301 公告编号：2025-029 证券简称：振德医疗 | | | | | | | --- | --- | --- | --- | --- | --- | | 振德医疗用品股份有限公司 | | | | | | | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 | | | | | | | 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 | | | | | | | 重要内容提示： | | | | | | | ? 本次会议是否有否决议案：无 | | | | | | | 一、 会议召开和出席情况 | | | | | | | (一)股东大会召开的时间：2025 年 8 月 11 日 | | | | | | | (二)股东大会召开的地点：浙江省绍兴市越城区皋埠街道香积路 55 号振德医 | | | | 疗 | | | 用品股份有限公司会议室 | | | | | | | (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | | | | | | | 份总数的比例（%） | | | 64.9660 | | | | (四)表决方式是否符合《公司法》及《 ...

8月11日，振德医疗今日收盘22.84元，上涨2.79%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到16.76倍，创158天以来新低，总市值60.86亿元。 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均56.56倍，行业中值39.76倍，振德医疗排 名第35位。 截至2025年一季报，共有3家机构持仓振德医疗，其中基金3家，合计持股数145.13万股，持股市值0.31 亿元。 最新一期业绩显示，2025年一季报，公司实现营业收入9.92亿元，同比2.87%；净利润5124.19万元，同 比-30.19%，销售毛利率34.28%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)4振德医疗16.7615.801.0760.86亿行业平均 56.5652.664.92118.97亿行业中值39.7639.192.9457.67亿1九安医疗11.2811.400.89190.28亿2英科医疗 15.1416.331.35239.25亿3山东药玻16.1616.211.86152.83亿5新华医疗17.1715.911.40110.05亿6奥美医疗 17.1816.831.7762. ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、通知债权人的原由 振德医疗用品股份有限公司（以下简称"公司"）分别于 2025 年 7 月 23 日、8 月 11 日召开第三届董事会第二十二次会议、第三届监 事会第十九次会议以及 2025 年第一次临时股东大会，审议通过《关 于变更部分回购股份用途并注销的议案》，同意将由公司回购的第一 期员工持股计划未解锁的 615,667 股公司股份用途由"用于实施员工 持股计划"变更为"注销并减少公司注册资本"。本次回购股份注销 完成后，公司总股本将由 266,451,202 股减少为 265,835,535 股，注 册资本将由 266,451,202 元减少为 265,835,535 元。具体内容详见公 司 2025 年 7 月 24 日在上海证券交易所网站披露的《关于变更部分回 购股份用途并注销的公告》（公告编号：2025-025）。 证券代码：603301 证券简称：振德医疗 公告编号：2025-031 振德医疗用品股份有限公司 关于注销回购股份减少注册资本 暨通知债权人的公告 ...